Lymphoma
44 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary goal of Hodgkin lymphoma treatment?

  • To prevent the spread of lymphoma cells
  • To cure the disease (correct)
  • To reduce treatment duration
  • To alleviate pain and discomfort

    • Which treatment method combines chemotherapy with localized treatment for early-stage disease?

  • Six to eight courses of combination chemotherapy
  • Monoclonal antibodies
  • Extended field radiotherapy (correct)
  • Autologous stem cell transplantation

    • Which chemotherapy regimen is specifically mentioned for advanced Hodgkin lymphoma treatment?

  • ABVD (correct)
  • GVD
  • eBEACOPP
  • ICE

    • Which of the following factors is associated with a higher cure rate in Hodgkin lymphoma?

    <p>Early-stage favorable disease</p> Signup and view all the answers

    What are the long-term treatment goals for Hodgkin lymphoma patients?

    <p>To minimize side effects and assess toxicity risks</p> Signup and view all the answers

    What does ABVD stand for in the context of chemotherapy for Hodgkin lymphoma?

    <p>Adriamycin, Bleomycin, Vincristine, Dacarbazine</p> Signup and view all the answers

    How does the cure rate for Hodgkin lymphoma patients change with disease recurrence?

    <p>Many can still be cured with further treatment</p> Signup and view all the answers

    What does a staging classification of 'A' indicate in Hodgkin's Lymphoma?

    <p>Absence of symptoms related to the disease.</p> Signup and view all the answers

    Which investigation is best for confirming the diagnosis of Hodgkin's Lymphoma?

    <p>Excision biopsy of the lymph node.</p> Signup and view all the answers

    What blood laboratory finding is common in Hodgkin's Lymphoma due to reactive responses?

    <p>Normochromic normocytic anemia.</p> Signup and view all the answers

    In which category of Hodgkin's Lymphoma staging would involvement of the spleen be classified?

    <p>Category S.</p> Signup and view all the answers

    Which is a potential complication related to high blood uric acid levels in the context of Hodgkin's Lymphoma?

    <p>Secondary gout.</p> Signup and view all the answers

    Which cytogenetic abnormality is most commonly associated with Burkitt’s Lymphoma?

    <p>t (8;14)</p> Signup and view all the answers

    What is a key histological feature of Hodgkin’s Lymphoma?

    <p>Reed-Sternberg cells</p> Signup and view all the answers

    Which of the following is a risk factor specifically associated with Hodgkin's Lymphoma?

    <p>Acquired immunodeficiency</p> Signup and view all the answers

    What diagnostic method is essential for confirming the presence of Reed-Sternberg cells?

    <p>Histological examination</p> Signup and view all the answers

    What staging system is commonly used to classify Hodgkin’s Lymphoma?

    <p>Ann Arbor system</p> Signup and view all the answers

    Which finding in cytogenetic abnormalities is associated with Follicular Lymphoma?

    <p>t (14;18)</p> Signup and view all the answers

    What is the role of immunophenotyping in diagnosing lymphomas?

    <p>To identify antigenic molecules</p> Signup and view all the answers

    What feature distinguishes non-Hodgkin’s Lymphoma from Hodgkin’s Lymphoma?

    <p>Presence of Reed-Sternberg cells</p> Signup and view all the answers

    Which statement about lymphomas is correct regarding their incidence?

    <p>The overall incidence of lymphomas is approximately 5-10 cases per 100,000 population annually.</p> Signup and view all the answers

    Which of the following cytogenetic abnormalities is associated with Mantle Cell Lymphoma?

    <p>t (11;14)</p> Signup and view all the answers

    Which stage of Non-Hodgkin Lymphoma typically requires a lumbar puncture for staging?

    <p>High risk of CNS involvement</p> Signup and view all the answers

    Among the following conditions, which is NOT typically considered a differential diagnosis for Non-Hodgkin lymphoma?

    <p>Pancreatitis</p> Signup and view all the answers

    What prognostic factor significantly influences the treatment approach for Non-Hodgkin lymphoma?

    <p>Type and stage of lymphoma</p> Signup and view all the answers

    Which characteristic would warrant a lymph node biopsy in suspected Non-Hodgkin lymphoma?

    <p>Persistent size for more than four to six weeks</p> Signup and view all the answers

    Which imaging method is primarily utilized in the workup for staging Non-Hodgkin lymphoma?

    <p>CT scan or PET scan</p> Signup and view all the answers

    What is the typical stage of disease at presentation for most patients with Diffuse Large B-Cell Lymphoma?

    <p>Stage III or IV</p> Signup and view all the answers

    Which of the following is a key histological feature of Diffuse Large B-Cell Lymphoma?

    <p>Presence of large B-cell origin cells such as centroblasts or immunoblasts</p> Signup and view all the answers

    Which treatment combination is considered the standard regimen for Diffuse Large B-Cell Lymphoma?

    <p>CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Predisolone)</p> Signup and view all the answers

    What genetic anomaly is associated with a relatively good prognosis in diffuse large B-cell lymphoma?

    <p>3q27 translocation showing BCL-6 overexpression</p> Signup and view all the answers

    What symptom is commonly associated with patients suffering from Diffuse Large B-Cell Lymphoma?

    <p>Night sweats</p> Signup and view all the answers

    What role does Rituximab play in the treatment of Diffuse Large B-Cell Lymphoma?

    <p>It is effective both alone and in combination with chemotherapy.</p> Signup and view all the answers

    What is one of the potential complications in patients with Non-Hodgkin Lymphoma (NHL) that can arise during evaluation?

    <p>Life-threatening infections</p> Signup and view all the answers

    What is the first-line treatment approach for early-stage non-Hodgkin lymphoma?

    <p>Radiotherapy</p> Signup and view all the answers

    Which factor is least associated with determining the risk classification in non-Hodgkin lymphoma?

    <p>Patient age</p> Signup and view all the answers

    Which complication is commonly associated with adult T-cell leukemia-lymphoma?

    <p>Hypercalcemia</p> Signup and view all the answers

    What characterizes Follicular Lymphoma compared to other NHL subtypes?

    <p>Constitutive BCL-2 expression</p> Signup and view all the answers

    In which scenario would chemotherapy be combined with immunotherapy?

    <p>Stage II bulky disease</p> Signup and view all the answers

    Which type of lymphoma is particularly characterized by painless lymphadenopathy?

    <p>Follicular Lymphoma</p> Signup and view all the answers

    What scoring range indicates a 'Low risk' classification in non-Hodgkin lymphoma?

    <p>0-1 adverse factors</p> Signup and view all the answers

    Which complication is typically associated with lymphoplasmacytic lymphoma?

    <p>Hyperviscosity syndrome</p> Signup and view all the answers

    Which treatment option is least likely to be recommended for non-Hodgkin lymphoma patients?

    <p>Surgery</p> Signup and view all the answers

    Which of the following is a recognized complication of small lymphocytic lymphoma?

    <p>Autoimmune hemolytic anemia and thrombocytopenia</p> Signup and view all the answers

    Study Notes

    Hodgkin Lymphoma Overview

    • Stage IV Hodgkin lymphoma (HL) can be cured despite widespread disease.
    • More than 80% of HL patients achieve a cure with current treatment strategies, rising to 90% in younger or early-stage patients.
    • Recurrence does not preclude future cures; many patients become long-term survivors.

    Treatment Goals

    • Aim for a cure across all stages of HL.
    • Minimize both short-term and long-term complications from treatment.
    • Balance toxicity risks with treatment benefits.

    Treatment Options

    • Chemotherapy: Often the first line of treatment.
    • Radiotherapy: Effective for early stages (IA/IIA); can be combined with chemotherapy.
    • Immunotherapy: Includes monoclonal antibodies and checkpoint inhibitors.
    • Stem Cell Transplantation: Considered in advanced or relapsed cases.

    Chemotherapy Regimens

    • ABVD regimen:
      • Adriamycin
      • Bleomycin
      • Vinblastine
      • Dacarbazine
    • Alternative regimens:
      • eBEACOPP: a more intensive combination for certain cases.
      • AVD: excludes bleomycin for patients with lung issues.
      • GVD: includes gemcitabine, vinorelbine, and liposomal doxorubicin.
    • Treatment duration typically ranges from six to eight courses depending on disease stage.

    Cytogenetic Abnormalities

    • Burkitt’s Lymphoma: t(8;14) linked to C-Myc protein overexpression.
    • Follicular Lymphoma: t(14;18) results in BCL-2 expression.
    • Mantle Cell Lymphoma: t(11;14) leads to BCL-1 overexpression.
    • Large Cell Lymphoma: characterized by BCL-6 expression.

    Diagnosis and Investigations

    • Histological assessment of lymph nodes is crucial for diagnosis; often confirmed with excision biopsy.
    • Immunophenotyping and molecular techniques assist in accurate diagnosis.
    • Common laboratory findings include normochromic normocytic anemia, elevated LDH in advanced cases, and abnormal liver functions.
    • Imaging studies (CT, MRI, PET scans) are employed to assess disease extent, including nodal and extra-nodal sites.

    Staging System

    • Stages I-IV determine disease spread; A, B, E, S sub-classifications provide additional context.
    • Category A: No B symptoms (fever, weight loss, night sweats).
    • Category B: Presence of B symptoms; may necessitate more intensive treatment.
    • Category E: HL cells present in extra-lymphatic tissues.
    • Category S: HL cells involved in the spleen.

    Incidence and Demographics

    • Lymphoma incidence: 5-10 cases per 100,000 annually, with a male predominance of 3:2.
    • Non-Hodgkin’s Lymphoma is twice as prevalent as Hodgkin’s Lymphoma.

    Non-Hodgkin Lymphoma (NHL) Overview

    • Majority of patients present with stage III or IV disease.
    • Sudden transformation to aggressive diffuse tumors possible, associated with a Leukaemic phase.
    • First-line treatments include single oral agents (Chlorambucil, Cyclophosphamide) or CVP (Cyclophosphamide, Vincristine, Prednisolone).
    • Combination therapies may involve Fludarabine, Mitozantrone, or Rituximab (anti-CD20).

    Diffuse Large B-Cell Lymphoma (DLBCL)

    • Characterized by rapid progression and high-grade lymphadenopathy.
    • Histologically defined by large B-cell forms (centroblasts, immunoblasts).
    • Linked to 3q27 translocation and BCL-6 overexpression, offering better prognosis.
    • Common across all ages, more prevalent in older adults, representing one-third of lymphomas.
    • Symptoms include night sweats, fever, weight loss, and lymphadenopathy; can also affect extranodal sites (GIT, testis, brain, bone).

    DLBCL Treatment Protocols

    • standard treatment regimen is CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone).
    • Addition of Rituximab has enhanced survival rates.
    • Chemotherapy administered every 3 weeks for 6-8 cycles.
    • Radiotherapy is used for bulky masses post-chemotherapy.

    Complications of NHL

    • Emergent complications can complicate treatment; early identification is crucial.
    • Life-threatening issues include hyperleukocytosis, hypercalcemia in T-cell leukemia-lymphoma, and pericardial tamponade.
    • Other complications: hyperviscosity syndrome, hepatic dysfunction, venous thromboembolism, autoimmune hemolytic anemia, and thrombocytopenia.

    Prognosis and Risk Factors

    • Prognosis is influenced by histopathology, disease extent, and patient condition.
    • Risk classified based on scoring system: low (0-1 factors), intermediate (2 factors), poor (≥3 factors).
    • Immunodeficiency predisposes patients to lymphoma and correlates with poor therapeutic response.

    Follicular Lymphoma

    • Most common indolent NHL associated with t(14;18) translocation and BCL-2 expression.
    • Typically affects middle-aged to elderly patients, characterized by a benign course and painless lymphadenopathy.
    • Imaging through CT or PET scans is standard, with lumbar puncture reserved for high CNS involvement risk.

    Workup for NHL Diagnosis

    • Requires lymph node/tissue biopsy for significant enlargement, persistent symptoms, or size increase.
    • Immunophenotypic analysis and bone marrow biopsy may be necessary for staging.
    • Utility of PET scans is increasing, minimizing the need for bone marrow aspirations.

    Differential Diagnosis

    • Conditions mimicking NHL symptoms include Hodgkin lymphoma, Epstein-Barr virus infection, SLE, and malignancies (e.g., nasopharyngeal carcinoma).
    • Other benign conditions like toxoplasmosis and mycobacterial infections can also present similarly.

    Treatment Variation for NHL

    • Treatment strategy is highly individualized based on tumor stage, type, grade, and patient-specific factors such as age and overall health.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Hodgkin's Lymphoma Past Paper PDF
    Lymphoma Non-Hodgkins Lymphoma PDF

    Description

    This quiz covers the essential aspects of Hodgkin Lymphoma, including its stages, treatment goals, and various treatment options such as chemotherapy, radiotherapy, immunotherapy, and stem cell transplantation. Learn about the effectiveness of different regimens and the importance of minimizing complications while aiming for a cure.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser